Pfizer’s Nurtec and Astrazeneca’s Breztri Share Top Ranking in 2024 Digital Marketing Competency Report

WALTHAM, Mass.--(BUSINESS WIRE)--Dec 5, 2024--

Trinity Life Sciences, the leader in strategy, insights and analytics for the life sciences industry, released its fourth annual TGaS Digital Marketing Competency Report assessing the digital marketing presence for patients across 150+ biopharma brands. The study evaluates the brands across five categories and more than 100 characteristics to establish a brand digital competency ranking.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241205305270/en/

Brands that topped the 2024 Digital Marketing Competency Report’s list include:

The Digital Marketing Competency Report ranks each individual brand on a scale ranging from Transformational to Novice. It examines time in market, therapeutic areas and impact on individual channels to give organizations unrivaled insight into how they can optimize their digital marketing execution. The study provides a comparison of biopharma brands to a sample of consumer brands outside of the pharmaceutical industry. This cross-industry perspective enables biopharma brands to identify where they lag and how they can enhance their digital and customer engagement strategies.

“The digital space is evolving at a faster pace than ever before, with more brands integrating digital-first strategies to better connect with patients and caregivers,” said Jerry Luciano, VP of Omnichannel Marketing, at TGaS Advisors, a Division of Trinity Life Sciences. “Over the past four years of conducting the study, we have observed an acceleration across the industry in driving an improved customer experience through digital.”

To download the summary of the report with the ranking of all 150+ brands, please visit TrinityLifeSciences.com or click here. The full report, including in-depth channel analysis and trends, is available to members of the TGaS Omnichannel Marketing network.

About Trinity Life Sciences

With almost 30 years of expertise, a best-in-the-business team and unrivaled access to data and analytics, Trinity Life Sciences is a modern partner to companies in the life sciences industry. Trinity combines strategy, insights and analytics to help life science executives with clinical and commercial decision-making. We serve over 350 pharmaceutical, biotech and medical device clients, helping them develop the right drugs and devices for today’s market and optimize them once in market. We have a diverse staff of over 1200 people and 11 global offices across the U.S., Europe and Asia. Ultimately, we know that every decision our clients make impacts a life, and when we help our clients achieve their goals, the world benefits. To learn more about how Trinity is elevating the industry and driving evidence to action, visit TrinityLifeSciences.com.

Cover image from Trinity Life Sciences’ fourth annual TGaS Digital Marketing Competency Report. (Photo: Business Wire)

NEW YORK (AP) — New York Yankees pitcher Carlos Rodón allowed six runs, five of them earned, and seven hits in 6 1/3 innings during his third and likely final minor league rehabilitation start for Triple-A Scranton/Wilkes-Barre on Tuesday.

Rodón will likely make his major league season debut over the weekend in Milwaukee, manager Aaron Boone said before the Yankees opened a three-game series with Texas.

Rodón allowed a two-run homer to Mickey Gasper on his changeup in the first inning and a solo homer to Kristian Campbell on a slider in the sixth in a 7-6 loss at Worcester. He threw 83 pitches, struck out four, walked two and has a 7.11 ERA in his three starts at Triple-A.

Rodón opened the season on the 15-day injured list as he recovered from surgery on Oct. 15 to remove loose bodies in his left elbow and shave a bone spur. He also had a setback in late March when he felt tightness in his right hamstring while throwing at the Yankees’ complex in Florida.

The left-hander signed $162 million, six-year contract with the Yankees in Dec. 2022. After struggling through injuries in 2023, Rodón has won 34 games in the last two seasons.

At the same time as Rodón’s start, Gerrit Cole made his fourth minor league start for High A Hudson Valley as he returns from reconstructive elbow surgery on March 11.

Cole allowed six runs and seven hits in 4 1/3 innings while throwing 69 pitches against Winston-Salem. Cole allowed solo homers to Caleb Bonemer and Kyle Lodise while also getting four strikeouts.

Cole is expected to need a few more minor league starts before making his season debut and first appearance since Game 5 of the 2024 World Series against the Dodgers. The Yankees have targeted a return in late May or early June for the 2023 AL Cy Young winner.

In the same game as Rodón, Anthony Volpe went 2 for 4. The Yankees opted to send Volpe to Scranton/Wilkes-Barre after his 20-day rehab window expired on Sunday following Oct. 14 surgery to repair a torn labrum in his left shoulder.

Volpe hit .250 (11 for 44) with one homer and six RBIs in 13 minor league games. He ended his rehab assignment in a 1-for-11 slide.

New York’s starting shortstop since 2023, Volpe has struggled at the plate, hitting .222 with 52 homers, 192 RBIs and 70 stolen bases over three seasons. His .212 average last year was 144th among 145 qualifiers, his play hampered after he hurt his hurt his left shoulder on May 3.

AP MLB: https://apnews.com/MLB

FILE - New York Yankees pitcher Carlos Rodón delivers against the Boston Red Sox during the first inning of Game 2 of an American League wild-card baseball playoff series, Oct. 1, 2025, in New York. (AP Photo/Yuki Iwamura, File)